Date Filed | Type | Description |
02/12/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
05/20/2009 |
NO ACT
| Form NO ACT - No Action Letter |
05/20/2009 |
NO ACT
| Form NO ACT - No Action Letter |
05/20/2009 |
NO ACT
| Form NO ACT - No Action Letter |
05/08/2009 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
04/09/2009 |
SC 13G/A
| PharmaNet Development Group Inc reports a 0% stake in OMB Number 3235-0145 Pharmanet Development Group, Inc. |
04/02/2009 |
8-K
| Quarterly results |
04/02/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-04-01 Registration Form: POS AM Reference AccNo: 0001341004-09-000662 |
04/02/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-04-01 Registration Form: POS AM Reference AccNo: 0001341004-09-000659 |
04/02/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-04-01 Registration Form: POS AM Reference AccNo: 0001341004-09-000658 |
04/02/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-04-01 Registration Form: POS AM Reference AccNo: 0001341004-09-000661 |
04/02/2009 |
EFFECT
| Form EFFECT -- Effectiveness Date: 2009-04-01 Registration Form: POS AM Reference AccNo: 0001341004-09-000660 |
03/31/2009 |
25-NSE
| Form 25-NSE -- |
03/30/2009 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |
03/25/2009 |
8-K
| Form 8-K -- Current report |
03/23/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
03/20/2009 |
SC TO-T/A
| Form SC TO-T/A -- Tender offer statement by Third Party [amend] |
03/17/2009 |
8-K
| Form 8-K -- Current report |
03/05/2009 |
SC TO-T/A
| Form SC TO-T/A -- Tender offer statement by Third Party [amend] |
02/26/2009 |
8-K
| Quarterly results |
02/19/2009 |
SC TO-T/A
| Form SC TO-T/A -- Tender offer statement by Third Party [amend] |
02/17/2009 |
SC 13G/A
| MORGAN STANLEY reports a 1% stake in PHARMANET DEVELOPMENT GROUP |
02/12/2009 |
SC 13G
| GALLEON MANAGEMENT L P reports a 0.4% stake in Pharmanet Development Group, Inc. |
02/12/2009 |
SC TO-T
| Form SC TO-T -- Tender offer statement by Third Party |
02/12/2009 |
SC 13G
| Invesco Ltd. reports a 8.5% stake in Pharmanet Development Group, Inc. |
02/11/2009 |
8-K
| Form 8-K -- Current report |
02/09/2009 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS INC reports a 4% stake in PHARMANET DEVELOPMENT GROUP |
02/03/2009 |
8-A12B/A
| Form 8-A12B/A -- Registration of securities [Section 12(b)] [amend] |
02/03/2009 |
SC TO-C
| Form SC TO-C -- Written communication relating to an issuer or third party |
02/03/2009 |
SC 13G/A
| BANK OF AMERICA CORP reports a |
02/03/2009 |
SC 13G/A
| BARCLAYS GLOBAL INVESTORS NA reports a 4.8% stake in PHARMANET DEVELOPMENT GROUP INC |
02/03/2009 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs:
|
"Agreement and Plan of Merger, among JLL PharmaNet Holdings, LLC, PDGI Acquisition Corp. and PharmaNet Development Group, Inc",
"Amendment No. 1 to Rights Agreement, between PharmaNet Development Group, Inc. and American Stock Transfer & Trust Company (as successor-in-interest to Wachovia Bank, N.A.), as rights agent",
"PHARMANET DEVELOPMENT GROUP AGREES TO BE ACQUIRED BY JLL PARTNERS. JLL TO COMMENCE TENDER OFFER FOR ALL SHARES OF COMMON STOCK." |
|
12/19/2008 |
SC TO-I/A
| Form SC TO-I/A -- Tender offer statement by Issuer [amend] |
12/19/2008 |
8-K
| Form 8-K -- Current report |
|